The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis C outcome. 2015

Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
Department of Hepatology and Acquired Immunodeficiences, Medical University of Warsaw, Warsaw, Poland. joannaj108@hotmail.com.

BACKGROUND Cytokine response against hepatitis C virus (HCV) is likely to determine the natural course of infection as well as the outcome of antiviral treatment. However, the role of particular cytokines remains unclear. The current study analyzed activation of cytokine response in chronic hepatitis C patients undergoing standard antiviral treatment. METHODS Twenty-two patients were treated with pegylated interferon and ribavirin. Twenty-six different cytokine transcripts were measured quantitatively in peripheral blood mononuclear cells (PBMC) before and after therapy and correlated with therapy outcome as well as with clinical and liver histological data. RESULTS We found that patients who achieved sustained virological response (SVR) showed higher pretreatment cytokine response when compared to subjects in whom therapy was unsuccessful. The differentially expressed factors included IL-8, IL-16, TNF-α, GM-CSF, MCP-2, TGF-β, and IP-10. Serum ALT activity and/or histological grading also positively correlated with the expression of IL-1α, IL-4, IL-6, IL-10, IL-12, IL-15, GM-CSF, M-CSF, MCP-2 and TGF-β. CONCLUSIONS Pretreatment activation of the immune system, as reflected by cytokines transcripts upregulation, positively correlates with treatment outcome and closely reflects liver inflammatory activity.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012254 Ribavirin A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. Ribovirin,Tribavirin,ICN-1229,Rebetol,Ribamide,Ribamidil,Ribamidyl,Ribasphere,Vilona,Viramide,Virazide,Virazole,ICN 1229,ICN1229

Related Publications

Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
June 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
July 2013, Hepatology international,
Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
May 2013, Human immunology,
Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
October 2010, Human immunology,
Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
March 1994, Journal of medical virology,
Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
June 2016, Journal of the Formosan Medical Association = Taiwan yi zhi,
Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
October 1992, American journal of clinical pathology,
Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
January 2007, The Journal of infectious diseases,
Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
November 1999, Journal of pediatric gastroenterology and nutrition,
Joanna Jabłońska, and Tomasz Pawłowski, and Tomasz Laskus, and Małgorzata Zalewska, and Małgorzata Inglot, and Sylwia Osowska, and Karol Perlejewski, and Iwona Bukowska-Ośko, and Kamila Caraballo Cortes, and Agnieszka Pawełczyk, and Piotr Ząbek, and Marek Radkowski
December 1999, Journal of hepatology,
Copied contents to your clipboard!